Search

Your search keyword '"Rawi, Reda"' showing total 232 results

Search Constraints

Start Over You searched for: Author "Rawi, Reda" Remove constraint Author: "Rawi, Reda" Search Limiters Full Text Remove constraint Search Limiters: Full Text
232 results on '"Rawi, Reda"'

Search Results

1. Rapid intra-host diversification and evolution of SARS-CoV-2 in advanced HIV infection

2. Cholesterol reduction by immunization with a PCSK9 mimic

3. Antibody-directed evolution reveals a mechanism for enhanced neutralization at the HIV-1 fusion peptide site

4. Soluble prefusion-closed HIV-envelope trimers with glycan-covered bases

5. HIV-1 neutralizing antibodies elicited in humans by a prefusion-stabilized envelope trimer form a reproducible class targeting fusion peptide

7. Cryo-EM structures of prefusion SIV envelope trimer

8. Vaccine elicitation and structural basis for antibody protection against alphaviruses

9. Co-immunization with hemagglutinin stem immunogens elicits cross-group neutralizing antibodies and broad protection against influenza A viruses

10. A single residue in influenza virus H2 hemagglutinin enhances the breadth of the B cell response elicited by H2 vaccination

11. Mutational fitness landscapes reveal genetic and structural improvement pathways for a vaccine-elicited HIV-1 broadly neutralizing antibody

12. Structural basis of glycan276-dependent recognition by HIV-1 broadly neutralizing antibodies

15. Extraordinary Titer and Broad Anti-SARS-CoV-2 Neutralization Induced by Stabilized RBD Nanoparticles from Strain BA.5.

16. Enhancing Anti-SARS-CoV-2 Neutralizing Immunity by Genetic Delivery of Enveloped Virus-like Particles Displaying SARS-CoV-2 Spikes

17. Preclinical Development of a Fusion Peptide Conjugate as an HIV Vaccine Immunogen

18. Improved pharmacokinetics of HIV-neutralizing VRC01-class antibodies achieved by reduction of net positive charge on variable domain

19. Diverse Murine Vaccinations Reveal Distinct Antibody Classes to Target Fusion Peptide and Variation in Peptide Length to Improve HIV Neutralization

21. Epitope-based vaccine design yields fusion peptide-directed antibodies that neutralize diverse strains of HIV-1

22. Bispecific antibody CAP256.J3LS targets V2-apex and CD4-binding sites with high breadth and potency

25. Vaccine-elicited murine antibody WS6 neutralizes diverse beta-coronaviruses by recognizing a helical stem supersite of vulnerability

26. Structure of an influenza group 2-neutralizing antibody targeting the hemagglutinin stem supersite

28. Structural basis for llama nanobody recognition and neutralization of HIV-1

29. Highly protective antimalarial antibodies via precision library generation and yeast display screening

30. Structural basis for llama nanobody recognition and neutralization of HIV-1 at the CD4-binding site

31. Development of Neutralization Breadth against Diverse HIV‐1 by Increasing Ab–Ag Interface on V2

32. Vaccination in a humanized mouse model elicits highly protective PfCSP-targeting anti-malarial antibodies

35. Structures of HIV-1 Neutralizing Antibody 10E8 Delineate the Mechanistic Basis of Its Multi-Peak Behavior on Size-Exclusion Chromatography

36. Sequence-Signature Optimization Enables Improved Identification of Human HV6-1-Derived Class Antibodies That Neutralize Diverse Influenza A Viruses

37. Potent SARS-CoV-2 neutralizing antibodies directed against spike N-terminal domain target a single supersite

38. Automated Design by Structure-Based Stabilization and Consensus Repair to Achieve Prefusion-Closed Envelope Trimers in a Wide Variety of HIV Strains

39. Identification and Structure of a Multidonor Class of Head-Directed Influenza-Neutralizing Antibodies Reveal the Mechanism for Its Recurrent Elicitation

40. Development of a 3Mut-Apex-Stabilized Envelope Trimer That Expands HIV-1 Neutralization Breadth When Used To Boost Fusion Peptide-Directed Vaccine-Elicited Responses

41. Structure of Super-Potent Antibody CAP256-VRC26.25 in Complex with HIV-1 Envelope Reveals a Combined Mode of Trimer-Apex Recognition

42. VRC34-Antibody Lineage Development Reveals How a Required Rare Mutation Shapes the Maturation of a Broad HIV-Neutralizing Lineage

46. Antibody Lineages with Vaccine-Induced Antigen-Binding Hotspots Develop Broad HIV Neutralization

47. Consistent elicitation of cross-clade HIV-neutralizing responses achieved in guinea pigs after fusion peptide priming by repetitive envelope trimer boosting

48. Longitudinal Analysis Reveals Early Development of Three MPER-Directed Neutralizing Antibody Lineages from an HIV-1-Infected Individual

49. Structural Survey of Broadly Neutralizing Antibodies Targeting the HIV-1 Env Trimer Delineates Epitope Categories and Characteristics of Recognition

Catalog

Books, media, physical & digital resources